GE HealthCare revenue climbs 7.2% in Q3 as sales top $5.5B
Key points
- GE HealthCare (NASDAQ:GEHC) reported third-quarter 2026 revenue of $5.5 billion, up 7.2%, while diluted earnings per share rose 39.1% to $1.36.
- Net income reached $615 million, adjusted EBIT margin rose to 16.6%, and the company reported a $23.7 billion backlog.
- Management increased its 2026 outlook, citing year-to-date performance and business momentum.
GE HealthCare (NASDAQ:GEHC) reported third-quarter 2026 revenue of $5.5 billion, up 7.2% year over year, and raised its full-year 2026 financial guidance.
Organic revenue grew 6.2%, while organic orders increased 4%, with a book-to-bill ratio of 1.03 times and a reported backlog of $23.7 billion.
Net income attributable to GE HealthCare rose to $615 million from $446 million, while adjusted earnings before interest and taxes increased to $913 million from $761 million.
The company’s net income margin increased to 11.1% from 8.7%, while its adjusted EBIT margin rose to 16.6% from 14.8%, with management citing volume, pricing and cost productivity.
GE HealthCare also reported operating cash flow of $907 million and free cash flow of $793 million, while management attributed the higher full-year outlook to year-to-date performance and business momentum.
Frequently asked questions
More from United States
VF Corporation Q2 earnings beat forecasts as revenue hits $2.695B
Avantor delivers 4.6% sales growth in third quarter
TE Connectivity Q4 sales grows 12% to $5.31 billion
Vertiv Q3 sales skyrockets 61% to $4.31 billion
OppFi Q3 revenue reaches $149.2 million
New Oriental revenue rallies 23.1% to $1.87 billion
